Cosmetics Europe (formerly Colipa) has pledged 8m to further its research programme into finding alternatives to animal testing, it announced at the annual SEURAT-1 meeting in Lisbon on 8 February. The new funds come on top of the 50m programme that the European Commission and Cosmetics Europe have jointly invested in SEURAT-1 under the 7th Framework Programme.
According to the association, the Cosmetics Europe Alternatives to Animal Testing (ATT) extended programme will focus on the pre-validation of promising toolbox test methods for skin sensitisation and data integration activities; the finalisation of the development and conduct pre-validation of the already developed 3D model for genotoxicity; and the refinement of eye irritation assays to address the last remaining gaps.
It is important that all ATT research, including SEURAT-1, is considered in the framework of creating a longer term road map to ensure that all European research efforts are united and research investments optimised in order to achieve workable solutions to replace animal testing as soon as possible, commented Cosmetics Europes general director, Bertil Heerink.
Sign in to see recommended stories here.